Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Leverger

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
La Revue Du Praticien|March 15, 2019
[Pediatric lumbar puncture: indications, execution and complications]Sébastien Héritier, Héloïse Torchin, Aude Verstraete, et al.
Haematologica|August 5, 2005
Risk factors for Gram-negative bacterial infections in febrile neutropeniaCatherine Cordonnier, Raoul Herbrecht, Agnès Buzyn, et al.
Blood|August 1, 2009
SPRED1 disorder and predisposition to leukemia in childrenEric Pasmant, Paola Ballerini, Helene Lapillonne, et al.
Bulletin Du Cancer|May 18, 2011
[Reduced intensity allogenic hematopoietic stem cell transplantation in children]Catherine Paillard, Patrick Lutz, Gérard Michel, et al.
BMC Cancer|June 30, 2006
Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemiaBenoit Brethon, Anne Auvrignon, Claire Galambrun, et al.
British Journal of Haematology|April 19, 2022
Single-dose (4.5 mg/m<sup>2</sup> ) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemiaChloé Dhunputh, Marion Strullu, Arnaud Petit, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Sporadic Burkitt Lymphoma Presenting as Intestinal Polyposis in a ChildSabah Boudjemaa, Linda Dainese, Joseph Khoury, et al.
JAMA Oncology|July 17, 2015
Vemurafenib Use in an Infant for High-Risk Langerhans Cell HistiocytosisSébastien Héritier, Mathilde Jehanne, Guy Leverger, et al.
Pediatric Blood & Cancer|August 23, 2020
Preoperative 3D reconstruction images for paediatric tumours: Advantages and drawbacksSabine Irtan, Erik Hervieux, Hélène Boutroux, et al.
Pediatric Blood & Cancer|March 30, 2022
Ex vivo drug sensitivity profiling-guided treatment of a relapsed pediatric mixed-phenotype acute leukemia with venetoclax and azacitidineFanny Gonzales, Audrey Guilmatre, Adeline Barthélémy, et al.
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
La Revue Du Praticien|March 15, 2019
[Pediatric lumbar puncture: indications, execution and complications]Sébastien Héritier, Héloïse Torchin, Aude Verstraete, et al.
Haematologica|August 5, 2005
Risk factors for Gram-negative bacterial infections in febrile neutropeniaCatherine Cordonnier, Raoul Herbrecht, Agnès Buzyn, et al.
Blood|August 1, 2009
SPRED1 disorder and predisposition to leukemia in childrenEric Pasmant, Paola Ballerini, Helene Lapillonne, et al.
Bulletin Du Cancer|May 18, 2011
[Reduced intensity allogenic hematopoietic stem cell transplantation in children]Catherine Paillard, Patrick Lutz, Gérard Michel, et al.
BMC Cancer|June 30, 2006
Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemiaBenoit Brethon, Anne Auvrignon, Claire Galambrun, et al.
British Journal of Haematology|April 19, 2022
Single-dose (4.5 mg/m<sup>2</sup> ) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemiaChloé Dhunputh, Marion Strullu, Arnaud Petit, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 13, 2016
Sporadic Burkitt Lymphoma Presenting as Intestinal Polyposis in a ChildSabah Boudjemaa, Linda Dainese, Joseph Khoury, et al.
JAMA Oncology|July 17, 2015
Vemurafenib Use in an Infant for High-Risk Langerhans Cell HistiocytosisSébastien Héritier, Mathilde Jehanne, Guy Leverger, et al.
Pediatric Blood & Cancer|August 23, 2020
Preoperative 3D reconstruction images for paediatric tumours: Advantages and drawbacksSabine Irtan, Erik Hervieux, Hélène Boutroux, et al.
Pediatric Blood & Cancer|March 30, 2022
Ex vivo drug sensitivity profiling-guided treatment of a relapsed pediatric mixed-phenotype acute leukemia with venetoclax and azacitidineFanny Gonzales, Audrey Guilmatre, Adeline Barthélémy, et al.
Pageof 20